Larry Goldstein, Ph.D.
Larry S.B. Goldstein, Ph.D., is a professor of cellular and molecular medicine at the University of California, San Diego (UCSD) School of Medicine. His research is focused on understanding the molecular mechanisms of intracellular movement in neurons and the role of transport dysfunction in neurodegenerative diseases. His lab provided the first molecular descriptions of kinesin structure and organization, and has recently discovered important links between transport processes and diseases such as Alzheimer's disease and Huntington's disease. Goldstein received a doctorate in genetics from the University of Washington, Seattle, and a bachelor's degree in biology and genetics from the University of California, San Diego. He conducted postdoctoral research at the University of Colorado at Boulder and the Massachusetts Institute of Technology.
Fred H. Gage, Ph.D.
Fred H. Gage, Ph.D., is a professor in the Laboratory of Genetics at the Salk Institute for Biological Studies. His research is concentrated on the adult central nervous system and unexpected plasticity and adaptability to environmental stimulation that remains throughout the life of all mammals. Gage's lab showed that, contrary to accepted dogma, human beings are capable of growing new nerve cells throughout life. Small populations of immature nerve cells are found in the adult mammalian brain, a process called neurogenesis. Gage is working to understand how these cells can be induced to become mature functioning nerve cells in the adult brain and spinal cord. Gage received a doctorate from The Johns Hopkins University and a bachelor's degree from the University of Florida. He has served on many advisory boards and is a past President of the Society for Neuroscience. He is a fellow of The National Academy of Sciences, the Institute of Medicine of the National Academy of Sciences and the American Academy of Arts and Sciences.
Evan Snyder, M.D., Ph.D.
Evan Snyder, M.D., Ph.D., is professor and director of the Stem Cells and Regeneration program at the Burnham Institute for Medical Research. He and his lab study stem cell biology to provide insights into many areas, such as developmental biology, homeostasis in the normal adult and recovery from injury. His lab has engaged in a multidisciplinary approach, simultaneously exploring the basic biology of stem cells, their role throughout the lifetime of an individual, as well as their therapeutic potential. Taken together, they believe these bodies of knowledge will glean the greatest benefit for scientists and, most importantly, for patients.
Snyder earned his medical degree and his doctorate in neuroscience from the University of Pennsylvania. He completed residencies in pediatrics and neurology at Children's Hospital-Boston and postdoctoral research at Harvard Medical School.
Martin Friedlander, M.D., Ph.D.
Martin Friedlander, M.D., Ph.D., is a professor in the Department of Cell Biology and the Graduate Program in Macromolecular and Cellular Structure and Chemistry at The Scripps Research Institute. He is also a staff ophthalmologist and chief of the retina service at Scripps Clinic and Green Hospital. His research interests focus on understanding basic underlying mechanisms of ocular angiogenesis and identifying therapeutic approaches to treating neovascular eye diseases such as macular degeneration and diabetic retinopathy. His laboratory has developed a number of novel angiostatic compounds and over the past decade has focused on understanding the role of endothelial and myeloid stem cells in normal and abnormal ocular angiogenesis. He has also had a long-standing interest in targeting, translocation and integration of polytopic membrane proteins including rhodopsin and sodium-calcium exchangers.
Friedlander received a medical degree at the State University of New York, Downstate Medical Center, a doctorate at the University of Chicago and completed his undergraduate education at Bowdoin College in Brunswick, Maine. He did his post-doctoral training at the Rockefeller University and completed his clinical training in ophthalmology and retina at UCLA's Jules Stein Eye Institute before joining the faculty at The Scripps Research Institute.
Anjana Rao, Ph.D.
Anjana Rao, Ph.D., is a professor of Signaling and Gene Expression Research at the La Jolla Institute for Allergy and Immunology. Her research focuses on understanding how signaling pathways control gene expression, using T cells and other cells of the immune system as models. A member of the National Academy of Sciences, she received her undergraduate and master's degrees from Osmania University in India and her Ph.D. from Harvard University. After many years as a faculty member at the Harvard Medical School and the Immune Disease Institute in Boston, she joined the La Jolla Institute in 2010. She has worked on signaling and gene transcription for many years, is a member of numerous advisory panels, and has received several major awards.